Search
for

    Glossary Lithium Carbonate

    medication used to treat mood disorders like bipolar disorder

    Lithium Carbonate (Li2CO3) is a medication commonly used to treat mood disorders such as bipolar disorder. It helps to stabilize mood and reduce the frequency and severity of manic episodes. In a biological context, lithium ions can influence neurotransmitter activity and neuronal excitability, which are crucial for mood regulation.

    Related Terms

    Sort by

    Research

    30 / 1000+ results
      Early Cardiac Damage Following Single and Combined Exposure to Lithium Carbonate and Lead Acetate in Rats: A Toxicological Perspective

      research EARLY CARDIAC DAMAGE FOLLOWING SINGLE AND COMBINED EXPOSURE TO LITHIUM CARBONATE AND LEAD ACETATE IN RATS: A TOXICOLOGICAL PERSPECTIVE

      January 2025 in “Exploratory Animal and Medical Research”
      Among adult male rats, this study found that combined exposure to lithium carbonate and lead acetate over 28 days led to synergistic cardiotoxic effects, evidenced by oxidative stress, ECG abnormalities, and molecular markers of increased apoptosis, despite no observable structural damage to myocardial tissue.
      Hair Loss During Lithium Treatment

      research Hair loss during lithium treatment

      29 citations , July 1982 in “British Journal of Dermatology”
      This article discusses hair loss linked to lithium treatment but reports no new clinical findings.

      research Follicular mycosis fungoides associated with lithium

      17 citations , February 2001 in “Journal of the American Academy of Dermatology”
      This case report suggests that lithium, either alone or with haloperidol, may induce skin changes resembling follicular mycosis fungoides.

      research Purpura Associated with Lithium Intoxication

      2 citations , January 2015 in “Chinese Medical Journal”
      In this case report, purpura was associated with lithium treatment at therapeutic levels, highlighting the importance of monitoring for symptoms of intoxication even when lithium concentrations appear normal.
      Drug-Induced Alopecia

      research [Drug induced alopecia].

      4 citations , May 1999 in “PubMed”
      This article reviews various drugs reported to cause alopecia, including cytostatics and anticoagulants, but does not present new research results; it suggests that drug-related hair loss can be difficult to prove.

      research Cluster Headache-Acute and Prophylactic Therapy

      74 citations , February 2011 in “Headache The Journal of Head and Face Pain”
      This article reviews acute and prophylactic treatments for cluster headaches, highlighting sumatriptan injections, oxygen therapy, and verapamil as effective options, but reports no new clinical results.
      The Usual Treatment of Trigeminal Autonomic Cephalalgias

      research The Usual Treatment of Trigeminal Autonomic Cephalalgias

      19 citations , October 2013 in “Headache: The Journal of Head and Face Pain”
      This review discusses conventional and alternative treatments for trigeminal autonomic cephalalgias, including cluster headache, paroxysmal hemicrania, and SUNCT, and recommends specific medications without reporting new clinical findings.
      Hair Loss and Lithium

      research Hair Loss and Lithium

      18 citations , October 1984 in “International Journal of Dermatology”
      This article reviews the relationship between hair loss and lithium but does not provide any new clinical findings.

      research Lithium: one drug, five complications

      14 citations , December 2017 in “Journal of Intensive Care”
      Lithium poisoning can cause severe health complications and requires careful monitoring.
      Hair Loss in Psychopharmacology

      research Hair Loss in Psychopharmacology

      63 citations , March 2000 in “Annals of clinical psychiatry”
      This article reviews the association between psychopharmaceuticals and medication-induced alopecia, noting that hair regrowth typically occurs after discontinuing or reducing the medication, while mineral supplements' effectiveness remains unclear.
      Drug-Induced Acne: Causes, Diagnosis, and Treatment

      research Drug-induced acne

      52 citations , October 2016 in “Clinics in Dermatology”
      This review discusses various drugs that can cause drug-induced acne, noting specific clinical and histopathologic features, but reports no new clinical findings.
      Dermatologic Side Effects of Psychotropic Medications

      research Dermatologic Side Effects of Psychotropic Medications

      31 citations , October 2013 in “Psychosomatics”
      This review discusses cutaneous adverse effects of psychotropic medications and reports no new findings, emphasizing the importance of psychiatrists being aware of these potential skin reactions.
      Psychoactive Drugs and Skin

      research Psychoactive drugs and skin

      12 citations , June 2003 in “Journal of the European Academy of Dermatology and Venereology”
      This review discusses the range and management of adverse cutaneous reactions to psychotropic medications and emphasizes the need for awareness among clinicians, concluding with a call for careful monitoring and patient education.
      Psychotropic Medications and the Skin

      research Psychotropic Medications and the Skin

      8 citations , April 2015 in “Advances in Psychosomatic Medicine”
      This review discusses the complex relationship between psychotropic medications and the skin, focusing on cutaneous side effects, dermatologic uses, and psychiatric disorders with skin manifestations, but reports no new findings.
      Dermatological Adverse Effects With Lithium Use

      research Efectos adversos dermatológicos con uso de litio

      1 citations , December 2023 in “Revista médica de Chile”
      This review examines the dermatologic side effects of lithium, noting it can cause or worsen skin conditions like psoriasis and acne, potentially affecting medication adherence, but reports no new clinical results.
      Drug Information Analysis Service: Effectiveness of Cromolyn Sodium in Treating Asthma in Children Under 2 Years Old

      research Drug Information Analysis Service

      July 1994 in “Annals of Pharmacotherapy”
      Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.
      Summary of Findings on Psychotropic Medications

      research Table of Contents

      December 2006 in “The Brown University Psychopharmacology Update”
      This review discusses various psychiatric treatments including antipsychotics, insomnia medication, and mood stabilizers, but reports no new clinical results; the authors comment on existing findings and approvals.
      Drug-Induced Hair Loss and Hair Growth

      research Drug-Induced Hair Loss and Hair Growth

      147 citations , April 1994 in “Drug Safety”
      Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.
      Psoriasis of the Scalp: Diagnosis and Management

      research Psoriasis of the Scalp

      128 citations , January 2001 in “American Journal of Clinical Dermatology”
      This review provides an overview of scalp psoriasis treatments but presents no new clinical results; it highlights various options including coal tar, salicylic acid, corticosteroids, and vitamin D3 analogues.
      Adverse Cutaneous Reactions to Mood Stabilizers

      research Adverse Cutaneous Reactions to Mood Stabilizers

      47 citations , January 2003 in “American Journal of Clinical Dermatology”
      This article discusses the potential for severe adverse cutaneous drug reactions with mood-stabilizing agents, emphasizing the importance of monitoring and patient communication, but reports no new clinical findings.
      Acneiform Dermatoses

      research Acneiform Dermatoses

      45 citations , January 1998 in “Dermatology”
      This review examines acneiform eruptions, often drug-induced, highlighting that they differ from acne vulgaris in causes and characteristics, with no new clinical results reported.
      Features

      research FEATURES

      1 citations , March 1997 in “Journal of the American Pharmaceutical Association”
      This guideline summary, endorsed by six Spanish pediatric societies, outlines consensus recommendations for managing childhood asthma, emphasizing diagnosis, maintenance treatment with low-dose inhaled corticosteroids, and patient education for effective control.